Medicinal inhalation aerosol formulations containing budesonide

Patent 6039932 Issued on March 21, 2000. Estimated Expiration Date:

September 25, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Medicinal aerosol formulations
Patent #: 5225183
Issued on: 07/06/1993
Inventor: Purewal, et al.

Method and apparatus an aerosol container
Patent #: 5345980
Issued on: 09/13/1994
Inventor: Burt, et al.

Compressed gas packages using polyoxyethylene glyceryl oleates
Patent #: 5415853
Issued on: 05/16/1995
Inventor: Hettche, et al.

Medicinal aerosol formulations
Patent #: 5439670
Issued on: 08/08/1995
Inventor: Purewal, et al.

Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
Patent #: 5492688
Issued on: 02/20/1996
Inventor: Byron, et al.

Medicinal aerosol formulations
Patent #: 5605674
Issued on: 02/25/1997
Inventor: Purewal, et al.

Aerosol formulations containing propellant 134a and fluticasone propionate
Patent #: 5658549
Issued on: 08/19/1997
Inventor: Akehurst, et al.

Medicinal aerosol formulations
Patent #: 5674473
Issued on: 10/07/1997
Inventor: Purewal, et al.

Medicinal aerosol formulations
Patent #: 5681545
Issued on: 10/28/1997
Inventor: Purewal, et al.

Medicinal aerosol formulations
Patent #: 5683677
Issued on: 11/04/1997
Inventor: Purewal, et al.

More ...

Inventors

Application

No. 937520 filed on 09/25/1997

US Classes:

424/45, Organic pressurized fluid424/46Powder or dust containing

Examiners

Primary: Bawa, Raj

Attorney, Agent or Firm

Ringsred; Ted K., Howard; MarySusan, Sprague; Robert W.

Foreign Patent References

372777 EP. 06/13/1990
384371 EP. 08/13/1990
504112 EP. 09/13/1992
518601 EP. 12/13/1992
518600 EP. 12/13/1992
0533731 EP. 03/13/1993
534731 EP. 03/13/1993
550031 EP. 07/13/1993
605578 EP. 07/13/1994
617610 EP. 10/13/1994
0633019 EP. 01/13/1995
653205 EP. 05/13/1995
91/04011 WO. 04/13/1991
91/11496 WO. 08/13/1991
91/11495 WO. 08/13/1991
92/22287 WO. 12/13/1992
93/11745 WO. 06/13/1993
93/11747 WO. 06/13/1993
93/18746 WO. 09/13/1993
94/21228 WO. 09/13/1994
94/21229 WO. 09/13/1994
9508603 WO. 03/13/1995
95/15151 WO. 06/13/1995
9527476 WO. 10/13/1995
96/09816 WO. 04/13/1996
96/09831 WO. 04/13/1996
9619198 WO. 06/13/1996
96/18384 WO. 06/13/1996

International Class

A61K 009/12

Foreign Application Priority Data

1996-09-27 GB

Abstract

A pharmaceutical aerosol formulation, suitable for administration by oral or nasal inhalation, containing a suspension of particulate budesonide, hydrofluoroalkane propellant and, optionally, additional hydrofluoroalkane propellants, surfactant selected from oleic acid, sorbitan oleates and lecithin, and adjuvant have a Kauri-butanol value of at least 10.